BIIB vs OKLO · P/E 21, rev $9.89B vs rev $1.2M
Biogen Inc (BIIB) versus Oklo Inc. (OKLO) — a side-by-side from cached financials, not a winner call.
Biogen Inc (BIIB) is a drug manufacturers - general company listed on NASDAQ. It is led by Christopher A. Viehbacher.
Oklo Inc. (OKLO) is a utilities - regulated electric company listed on US.
Latest reported BIIB revenue for 2025-12-31 was $9.89B. Net income was $1.29B. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
Latest reported OKLO revenue for 2026-06-30 was $1.2M. Net income was -$81.6M. OKLO currently screens at market cap $8.25B.
BIIB currently screens at market cap $29.33B and trailing P/E 21.4. OKLO currently screens at market cap $8.25B.
Not investment advice. Open the BIIB and OKLO stock pages for the full models.
Not investment advice.